NUS Historical Income Statement

NUS Stock

USD 7.22 0.08 1.10%

Historical analysis of Nu Skin income statement accounts such as Gross Profit of 1.4 B can show how well Nu Skin Enterprises performed in making a profits. Evaluating Nu Skin income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Nu Skin's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Nu Skin Enterprises latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Nu Skin Enterprises is a good buy for the upcoming year.

Net Income Gross Profit

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nu Skin Enterprises. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

About NUS Income Statement Analysis

Nu Skin Enterprises Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Nu Skin shareholders. The income statement also shows NUS investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Nu Skin Income Statement Chart

At this time, Nu Skin's Interest Expense is comparatively stable compared to the past year. Gross Profit is likely to gain to about 1.4 B in 2024, whereas Total Revenue is likely to drop slightly above 1.8 B in 2024.

Total Revenue Gross Profit Other Operating Expenses Operating Income Extraordinary Items

Total Revenue

Total revenue comprises all receipts Nu Skin Enterprises generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Nu Skin Enterprises minus its cost of goods sold. It is profit before Nu Skin operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Nu Skin Enterprises. It is also known as Nu Skin overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Operating Income

Operating Income is the amount of profit realized from Nu Skin Enterprises operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Nu Skin Enterprises is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most accounts from Nu Skin's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Nu Skin Enterprises current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nu Skin Enterprises. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

	2021	2022	2023	2024 (projected)
Gross Profit	2.0B	1.6B	1.4B	1.4B
Total Revenue	2.7B	2.2B	2.0B	1.8B

Gross Profit Total Revenue

Nu Skin income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling General Administrative	Research Development	Selling And Marketing Expenses	Net Income From Continuing Ops	Non Operating Income Net Other	Tax Provision	Interest Income	Minority Interest	Reconciled Depreciation	Extraordinary Items	Non Recurring
Depreciation And Amortization		0.3	0.58	0.45	0.66	-0.02	-0.04	0.19	0.87	0.54	-0.01	0.03	0.01	-0.04	0.67	0.84	0.34	-0.19	0.0	0.02	0.43	0.09	0.4	-0.02	-0.47
Interest Expense	0.3		-0.05	-0.16	0.04	-0.63	-0.58	-0.39	0.34	-0.08	-0.58	0.19	-0.49	-0.65	0.06	0.39	-0.19	-0.5	-0.01	-0.81	0.48	-0.66	-0.32	0.65	-0.97
Total Revenue	0.58	-0.05		0.98	0.99	0.68	0.69	0.83	0.79	1.0	0.66	0.0	0.66	0.6	0.7	0.66	0.93	0.47	0.01	0.18	0.19	0.22	0.35	-0.19	-0.04
Gross Profit	0.45	-0.16	0.98		0.95	0.79	0.8	0.91	0.66	0.99	0.77	0.0	0.75	0.71	0.64	0.54	0.97	0.59	0.03	0.26	0.07	0.24	0.29	-0.25	0.09
Other Operating Expenses	0.66	0.04	0.99	0.95		0.58	0.6	0.75	0.86	0.98	0.57	-0.02	0.57	0.5	0.71	0.74	0.88	0.37	-0.03	0.11	0.26	0.18	0.37	-0.12	-0.13
Operating Income	-0.02	-0.63	0.68	0.79	0.58		0.99	0.92	0.14	0.71	0.98	0.02	0.95	0.92	0.33	0.02	0.82	0.9	0.19	0.58	-0.39	0.52	0.25	-0.53	0.57
Ebit	-0.04	-0.58	0.69	0.8	0.6	0.99		0.94	0.16	0.72	0.97	0.0	0.94	0.9	0.32	0.04	0.84	0.89	0.16	0.51	-0.4	0.49	0.2	-0.49	0.53
Ebitda	0.19	-0.39	0.83	0.91	0.75	0.92	0.94		0.34	0.85	0.9	-0.03	0.87	0.84	0.51	0.23	0.95	0.77	0.13	0.4	-0.26	0.28	0.11	-0.4	0.32
Cost Of Revenue	0.87	0.34	0.79	0.66	0.86	0.14	0.16	0.34		0.75	0.14	0.0	0.17	0.07	0.7	0.89	0.55	-0.03	-0.07	-0.11	0.51	0.1	0.46	0.08	-0.46
Total Operating Expenses	0.54	-0.08	1.0	0.99	0.98	0.71	0.72	0.85	0.75		0.69	-0.03	0.68	0.62	0.66	0.63	0.94	0.49	-0.01	0.19	0.15	0.21	0.31	-0.18	0.0
Income Before Tax	-0.01	-0.58	0.66	0.77	0.57	0.98	0.97	0.9	0.14	0.69		0.21	0.98	0.93	0.33	0.07	0.79	0.93	0.3	0.61	-0.33	0.54	0.29	-0.55	0.53
Total Other Income Expense Net	0.03	0.19	0.0	0.0	-0.02	0.02	0.0	-0.03	0.0	-0.03	0.21		0.24	0.14	0.05	0.25	-0.02	0.28	0.63	0.22	0.24	0.18	0.25	-0.18	-0.19
Net Income	0.01	-0.49	0.66	0.75	0.57	0.95	0.94	0.87	0.17	0.68	0.98	0.24		0.82	0.32	0.08	0.78	0.95	0.32	0.49	-0.32	0.58	0.29	-0.58	0.44
Income Tax Expense	-0.04	-0.65	0.6	0.71	0.5	0.92	0.9	0.84	0.07	0.62	0.93	0.14	0.82		0.32	0.03	0.73	0.79	0.25	0.73	-0.33	0.43	0.26	-0.43	0.61
Selling General Administrative	0.67	0.06	0.7	0.64	0.71	0.33	0.32	0.51	0.7	0.66	0.33	0.05	0.32	0.32		0.63	0.68	0.25	-0.09	0.15	0.4	0.08	0.43	-0.13	-0.22
Research Development	0.84	0.39	0.66	0.54	0.74	0.02	0.04	0.23	0.89	0.63	0.07	0.25	0.08	0.03	0.63		0.43	-0.12	-0.08	-0.03	0.61	0.06	0.39	0.04	-0.47
Selling And Marketing Expenses	0.34	-0.19	0.93	0.97	0.88	0.82	0.84	0.95	0.55	0.94	0.79	-0.02	0.78	0.73	0.68	0.43		0.67	0.05	0.23	0.01	0.18	0.2	-0.25	0.12
Net Income From Continuing Ops	-0.19	-0.5	0.47	0.59	0.37	0.9	0.89	0.77	-0.03	0.49	0.93	0.28	0.95	0.79	0.25	-0.12	0.67		0.38	0.46	-0.4	0.51	0.19	-0.51	0.46
Non Operating Income Net Other	0.0	-0.01	0.01	0.03	-0.03	0.19	0.16	0.13	-0.07	-0.01	0.3	0.63	0.32	0.25	-0.09	-0.08	0.05	0.38		0.2	-0.1	0.14	0.1	-0.14	-0.05
Tax Provision	0.02	-0.81	0.18	0.26	0.11	0.58	0.51	0.4	-0.11	0.19	0.61	0.22	0.49	0.73	0.15	-0.03	0.23	0.46	0.2		-0.3	0.69	0.51	-0.7	0.74
Interest Income	0.43	0.48	0.19	0.07	0.26	-0.39	-0.4	-0.26	0.51	0.15	-0.33	0.24	-0.32	-0.33	0.4	0.61	0.01	-0.4	-0.1	-0.3		-0.27	0.36	0.28	-0.47
Minority Interest	0.09	-0.66	0.22	0.24	0.18	0.52	0.49	0.28	0.1	0.21	0.54	0.18	0.58	0.43	0.08	0.06	0.18	0.51	0.14	0.69	-0.27		0.71	-0.8	0.58
Reconciled Depreciation	0.4	-0.32	0.35	0.29	0.37	0.25	0.2	0.11	0.46	0.31	0.29	0.25	0.29	0.26	0.43	0.39	0.2	0.19	0.1	0.51	0.36	0.71		-0.44	0.22
Extraordinary Items	-0.02	0.65	-0.19	-0.25	-0.12	-0.53	-0.49	-0.4	0.08	-0.18	-0.55	-0.18	-0.58	-0.43	-0.13	0.04	-0.25	-0.51	-0.14	-0.7	0.28	-0.8	-0.44		-0.61
Non Recurring	-0.47	-0.97	-0.04	0.09	-0.13	0.57	0.53	0.32	-0.46	0.0	0.53	-0.19	0.44	0.61	-0.22	-0.47	0.12	0.46	-0.05	0.74	-0.47	0.58	0.22	-0.61

Click cells to compare fundamentals

Nu Skin Account Relationship Matchups

Nu Skin income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	76.7M	120.2M	125.0M	72.5M	69.6M	51.2M
Interest Expense	19.2M	13.1M	11M	21.9M	25.2M	26.4M
Total Revenue	2.4B	2.6B	2.7B	2.2B	2.0B	1.8B
Gross Profit	1.8B	1.9B	2.0B	1.6B	1.4B	1.4B
Other Operating Expenses	2.2B	2.3B	2.4B	2.1B	1.9B	1.6B
Operating Income	190.8M	257.6M	234.0M	110.8M	48.3M	45.9M
Ebit	190.8M	211.4M	243.5M	159.3M	68.1M	64.7M
Ebitda	267.4M	331.6M	368.5M	231.8M	137.7M	249.1M
Cost Of Revenue	581.4M	658.0M	675.2M	630.9M	611.9M	377.1M
Total Operating Expenses	1.6B	1.7B	1.7B	1.4B	1.3B	1.2B
Income Before Tax	255.2M	256.2M	232.5M	89.0M	26.6M	25.2M
Total Other Income Expense Net	64.4M	(1.3M)	(1.5M)	(21.9M)	(21.7M)	(20.6M)
Net Income	173.6M	191.4M	147.3M	104.8M	8.6M	8.2M
Income Tax Expense	81.6M	64.9M	85.2M	(15.8M)	18.0M	17.1M
Selling General Administrative	616.0M	646.8M	666.4M	555.8M	546.9M	570.7M
Net Income Applicable To Common Shares	173.6M	191.4M	147.3M	104.8M	120.5M	135.7M
Research Development	23M	30.1M	23.3M	27.2M	22.6M	18.1M
Selling And Marketing Expenses	955.6M	1.0B	1.1B	879.6M	742.4M	888.3M
Net Income From Continuing Ops	173.6M	191.4M	147.3M	104.8M	58.5M	55.6M
Non Operating Income Net Other	(12.3M)	(1.3M)	(1.5M)	(21.9M)	(19.7M)	(20.7M)
Tax Provision	81.6M	64.9M	85.2M	(15.8M)	(16.9M)	(16.1M)
Interest Income	19.2M	13.1M	11M	13.5M	15.5M	15.1M
Reconciled Depreciation	76.7M	74.0M	76.3M	72.5M	70.9M	60.0M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for NUS Stock Analysis

When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

NUS Historical Income Statement

About NUS Income Statement Analysis

Nu Skin Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Operating Income

Nu Skin income statement Correlations

Nu Skin Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Nu Skin income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for NUS Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Total Revenue
Other Operating Expenses	+ 0.99	Total Revenue
Total Operating Expenses	+ 0.99	Gross Profit
Ebit	+ 0.99	Operating Income
Gross Profit	+ 0.98	Total Revenue
Total Operating Expenses	+ 0.98	Other Operating Expenses

Non Recurring	- 0.97	Interest Expense
Tax Provision	- 0.81	Interest Expense
Extraordinary Items	- 0.8	Minority Interest
Extraordinary Items	- 0.7	Tax Provision
Minority Interest	- 0.66	Interest Expense
Income Tax Expense	- 0.65	Interest Expense